Impact of Availability of Showerpatch for Patients With Intravenous Catheters

NCT02324868 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2016-03-30

No results posted yet for this study

Summary

Venous catheters are necessary for the treatment of many patients. Showering with a venous catheter is often prohibited due to the infection risk when the insertion site becomes wet. Therefore these patients are challenged to keep the catheter insertion site dry and always covered with a dressing. Washing themselves is often impossible without assistance of a nurse or significant other. For patients with a catheter connected to an infusion line, it is even more difficult. Showerpatch is a newly developed dressing that safeguards the insertion site of an IV catheter from water during bathing activities. The purpose of this trial is to evaluate the impact of the availability of Showerpatch by comparing the outcomes in patients regarding the patient's autonomy in bathing activities, the material use and the time needed from caregivers in home care. Additionally qualitative data on patient's bathing activities and the use of Showerpatch will be collected.

Conditions

Interventions

DEVICE

Shower patch IV catheter protection

Shower patch will be available for the patient for bathing activities

DEVICE

Conventional IV catheter protection

No Shower patch will be provided during study period

Sponsors & Collaborators

  • BEDAL

    collaborator UNKNOWN
  • Remedus

    collaborator UNKNOWN
  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Godelieve A Goossens, PhD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-02-29
Completion
2016-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324868 on ClinicalTrials.gov